Operating Cash Flow (Statement)

$12.78B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$12.78Bperiod endingJun 30, 2026

BMY TTM Cash from Operations ($1.75B → $12.78B)

TTM operating cash flow (statement)

High-resolution chart · PNG

BMY operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	5,391,000,000
Mar 31, 2001	4,815,000,000
Dec 31, 2000	4,652,000,000
Sep 30, 2000	4,450,000,000
Jun 30, 2000	4,350,000,000
Mar 31, 2000	4,277,000,000
Dec 31, 1999	4,292,000,000
Sep 30, 1999	4,117,000,000
Jun 30, 1999	4,348,000,000
Mar 31, 1999	3,961,000,000
Dec 31, 1998	4,120,000,000
Sep 30, 1998	3,270,000,000
Jun 30, 1998	2,776,000,000
Mar 31, 1998	2,669,000,000
Dec 31, 1997	2,476,000,000
Sep 30, 1997	2,541,000,000
Jun 30, 1997	2,458,000,000
Mar 31, 1997	2,713,000,000
Dec 31, 1996	2,641,000,000
Sep 30, 1996	2,625,000,000
Jun 30, 1996	2,650,000,000
Mar 31, 1996	2,361,000,000
Dec 31, 1995	2,499,000,000
Sep 30, 1995	2,512,000,000
Jun 30, 1995	2,229,000,000
Mar 31, 1995	2,358,000,000
Dec 31, 1994	2,301,000,000
Sep 30, 1994	2,410,000,000
Jun 30, 1994	2,733,000,000
Mar 31, 1994	2,863,000,000
Dec 31, 1993	2,580,000,000
Sep 30, 1993	2,460,000,000
Jun 30, 1993	2,341,000,000
Mar 31, 1993	2,043,000,000
Dec 31, 1992	2,028,000,000
Sep 30, 1992	2,044,000,000
Jun 30, 1992	1,859,000,000
Mar 31, 1992	1,861,000,000
Dec 31, 1991	1,835,000,000
Sep 30, 1991	1,716,000,000
Jun 30, 1991	1,654,000,000
Mar 31, 1991	1,741,000,000
Dec 31, 1990	1,752,000,000